Sing George L 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.REGN,2026/11/4 申報
- 申報編號
- 0001225471-26-000004
- 申報時間
- 2026/11/4 16:11 ET
- 交易日
- 2026/11/2
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 11 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $2,038 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Sing George LCIK 0001225471 | 董事 |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/11/2 | Common Stock | M行使選擇權取得 | +7,830 | $376.69 | +$2,949,482.7 | 38,837 | 直接 | |
| 2026/11/2 | Common Stock | M行使選擇權取得 | +7,439 | $380.95 | +$2,833,887.05 | 46,276 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −1,224 | $960.57F1 | −$1,175,737.68 | 45,052 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −540 | $961.85F2 | −$519,399 | 44,512 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −2,522 | $962.61F3 | −$2,427,702.42 | 41,990 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −4,338 | $963.47F4 | −$4,179,532.86 | 37,652 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −2,670 | $964.57F5 | −$2,575,401.9 | 34,982 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −7,073 | $965.38F6 | −$6,828,132.74 | 27,909 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −1,522 | $966.27F7 | −$1,470,662.94 | 26,387 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −1,040 | $967.07F8 | −$1,005,752.8 | 25,347 | 直接 | |
| 2026/11/2 | Common Stock | S賣出處分 | −200 | $970.18F9 | −$194,036 | 25,147 | 直接 |
衍生性證券(表 II)
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/11/2 | Common Stock | M行使選擇權處分 | −7,830 | $0.00 | $0 | 0 | 直接 | |
| 2026/11/2 | Common Stock | M行使選擇權處分 | −7,439 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 1,224 shares of Company stock on November 2, 2026 at prices ranging from $960.03 to $960.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 540 shares of Company stock on November 2, 2026 at prices ranging from $961.76 to $961.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 2,522 shares of Company stock on November 2, 2026 at prices ranging from $962.07 to $962.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 4,338 shares of Company stock on November 2, 2026 at prices ranging from $963.00 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 2,670 shares of Company stock on November 2, 2026 at prices ranging from $964.10 to $964.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 7,073 shares of Company stock on November 2, 2026 at prices ranging from $965.00 to $965.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 1,522 shares of Company stock on November 2, 2026 at prices ranging from $966.02 to $966.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 1,040 shares of Company stock on November 2, 2026 at prices ranging from $967.00 to $967.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 200 shares of Company stock on November 2, 2026 at prices ranging from $970.16 to $970.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。